Drug Profile
Research programme: abuse resistant therapeutics - Pisgah
Alternative Names: ephedrine (abuse-deterrent) - Pisgah; hydrocodone/paracetamol (abuse-deterrent) - Pisgah; pseudoephedrine (abuse-deterrent) - PisgahLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pisgah Labs
- Class Morphinans
- Mechanism of Action Adrenergic receptor agonists; Adrenergic uptake inhibitors; Central nervous system stimulants; Opioid receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Attention-deficit hyperactivity disorder; Depressive disorders; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA (Intranasal)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA (PO)
- 16 Jul 2016 No recent reports of development identified for research development in Attention-deficit-hyperactivity-disorder in USA